CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals 		Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Congress Reports

 print this page   back


Page summary
Text size
Congress reports quick search
The latest news from International Congresses
 

Drug-related information may refer to unlicensed products or uses that may not be approved in your country. Please consult your local prescribing information for advice.


Congress Reports

Day 1, 3 September 2005

 Update on renin-angiotensin-system blockade in heart failure I

 Update on renin-angiotensin-system blockade in heart failure II

 Guidelines and beyond: Focus on the next move in lipid management I

 Guidelines and beyond: Focus on the next move in lipid management II

Day 2, 4 September 2005

 The future of inotropic therapy in heart failure I

 The future of inotropic therapy in heart failure II

 Guilty until proven innocent - the class effect dilemma I

 Guilty until proven innocent - the class effect dilemma II

 Problems with lipid control I

 Problems with lipid control II

Day 3, 5 September 2005

 Air pollution and cardiovascular disease

 New concepts and strategies in cardiac arrest

 High-density lipoprotein as anti-atherogenic agents I

 High-density lipoprotein as anti-atherogenic agents II

 Cardiovascular research in Europe - a near-death experience?

 Sudden cardiac death is a major threat in heart disease - how to prevent? I

 Sudden cardiac death is a major threat in heart disease - how to prevent? II

Day 4, 6 September 2005

 Towards the optimal cardiovascular risk score

 Progenitor cells for acute myocardial infarction

 Metabolic syndrome - an independent cardiovascular risk factor? I

 Metabolic syndrome - an independent cardiovascular risk factor? II

 Poster highlights: Treatment strategies for atrial fibrillation I

 Poster highlights: Treatment strategies for atrial fibrillation II

 Emerging drug options in atrial fibrillation I

 Emerging drug options in atrial fibrillation II

Day 5, 7 September 2005

 Drugs, more drugs, new drugs for CV disease

 Atherosclerosis, stem cells and cardiomyopathy

 Diabetes and acute myocardial infarction

 Section feedback  Send to a friend 
 Top of page
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions